Progress of anti-checkpoint therapy in metastatic colorectal cancer
Lizhen Zhu;Xuefeng Fang;Chenhan Zhong;Ying Yuan;Department of Medical Oncology;The Second Affiliated Hospital;Zhejiang University School of Medicine;Key Laboratory of Cancer Prevention and Intervention of Ministry of Education;The Second Affiliated Hospital;Zhejiang University School of Medicine;
..............page:143-144
..............page:145-149
Precision medicine in the treatment of pancreatic ductal adenocarcinoma
Jianlin Chen;Yunmian Chu;Jin He;Lei Zheng;Xu Che;Department of Hepatobiliary Oncology;Sun Yat-sen University Cancer Center;State Key Laboratory of Southern China;Collaborative Innovation Center for Cancer Medicine;Department of Abdominal Surgery;Cancer Hospital;Chinese Academy of Medical Sciences and Perking Union Medical College;Department of Surgery;Johns Hopkins University School of Medicine;Department of Oncology;The Sidney Kimmel Cancer Center;Department of Surgery;The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care;Johns Hopkins University School of Medicine;
..............page:150-155
Anticancer effect and enhanced chemotherapy potential of resveratrol in human pancreatic cancer cell lines
Sumei Chen;Ke Zhang;Yuanyuan Chen;Ruzhen Zheng;Penjun Zhao;Jianwei Zhu;Shuming Wu;Qinghua Deng;Shenglin Ma;Guangsu Xiong;Department of Radiation Oncology;Hangzhou Cancer Hospital;Department of Oncology;Hangzhou Cancer Hospital;Division of Gastroenterology and Hepatology;Renji Hospital;Shanghai Jiao Tong University;Shanghai Institute of Digestive Disease;Affiliated Hangzhou First People’s Hospital of Zhejiang Chinese Medical University;
..............page:156-164
..............page:165-168
..............page:169-173
..............page:174-178
..............page:179-184
..............page:185-188
..............page:189-193